CBD Life Sciences CBDL Stock
CBD Life Sciences Price Chart
CBD Life Sciences CBDL Financial and Trading Overview
| CBD Life Sciences stock price | 0.0002 USD |
| Previous Close | 0.00015 USD |
| Open | 0.0001 USD |
| Bid | 0.0001 USD x 125669892500 |
| Ask | 0.0002 USD x 1256392900 |
| Day's Range | 0.0001 - 0.0002 USD |
| 52 Week Range | 0.0001 - 0.001 USD |
| Volume | 559.06K USD |
| Avg. Volume | 36.03M USD |
| Market Cap | 911.14K USD |
| Beta (5Y Monthly) | 77.925 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CBDL Valuation Measures
| Enterprise Value | 94.34K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.1058965 |
| Price/Book (mrq) | 0.099999994 |
| Enterprise Value/Revenue | 0.529 |
| Enterprise Value/EBITDA | -1.818 |
Trading Information
CBD Life Sciences Stock Price History
| Beta (5Y Monthly) | 77.925 |
| 52-Week Change | -55.55% |
| S&P500 52-Week Change | 17.31% |
| 52 Week High | 0.001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000209 USD |
| 200-Day Moving Average | 0.0002948 USD |
CBDL Share Statistics
| Avg. Volume (3 month) | 36.03M USD |
| Avg. Daily Volume (10-Days) | 19.22M USD |
| Shares Outstanding | 4.56B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:300 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | -60.20% |
| Operating Margin (ttm) | -122.24% |
| Gross Margin | 45.05% |
| EBITDA Margin | -29.073% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | -45.076% |
Income Statement
| Revenue (ttm) | 178.45K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 35.79% |
| Gross Profit (ttm) | 80.41K USD |
| EBITDA | -51880 USD |
| Net Income Avi to Common (ttm) | -107437 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 82 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.159 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19586 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of CBD Life Sciences
| Country | United States |
| State | AZ |
| City | Scottsdale |
| Address | 10953 N. Frank Lloyd Wright Boulevard |
| ZIP | 85259 |
| Phone | 480-209-1720 |
| Website | https://www.thecbdvault.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.
Q&A For CBD Life Sciences Stock
What is a current CBDL stock price?
CBD Life Sciences CBDL stock price today per share is 0.0002 USD.
How to purchase CBD Life Sciences stock?
You can buy CBDL shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CBD Life Sciences?
The stock symbol or ticker of CBD Life Sciences is CBDL.
Which industry does the CBD Life Sciences company belong to?
The CBD Life Sciences industry is Drug Manufacturers - Specialty & Generic.
How many shares does CBD Life Sciences have in circulation?
The max supply of CBD Life Sciences shares is 4.56B.
What is CBD Life Sciences Price to Earnings Ratio (PE Ratio)?
CBD Life Sciences PE Ratio is now.
What was CBD Life Sciences earnings per share over the trailing 12 months (TTM)?
CBD Life Sciences EPS is 0 USD over the trailing 12 months.
Which sector does the CBD Life Sciences company belong to?
The CBD Life Sciences sector is Healthcare.